{{Rsnum
|rsid=1884613
|Gene=R3HDML
|Chromosome=20
|position=44351775
|Orientation=plus
|GMAF=0.2479
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 62.3 | 35.8 | 1.9
| HCB | 34.3 | 40.0 | 25.7
| JPT | 22.0 | 65.9 | 12.2
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 34.3 | 40.0 | 25.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

[[rs1884613]] associated with [[type-2 diabetes]] in a Scandinavian population {{PMID|17827402}}

{{PMID Auto
|PMID=20361036
|Title=Gene-gene interactions lead to higher risk for development of type 2 diabetes in an ashkenazi jewish population
|OA=1
}}

{{PMID Auto
|PMID=21633728
|Title=Hepatocyte nuclear factor 4 alpha P2 promoter variants associate with insulin resistance
}}

{{PMID Auto
|PMID=21983932
|Title=Association of Hepatocyte Nuclear Factor 4 Alpha Polymorphisms with Type 2 Diabetes With or Without Metabolic Syndrome in Malaysia
}}

{{PMID Auto
|PMID=15734869
|Title=Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 people.
}}

{{PMID Auto
|PMID=16186411
|Title=Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians.
|OA=1
}}

{{PMID Auto
|PMID=17894829
|Title=Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women.
}}

{{PMID Auto
|PMID=18728231
|Title=Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}